Guidelines
|
LABORATORY PROCEDURES FOR ANIMAL & HUMAN CELL LINES
Appendix REFERENCE NO: AHC/1998/2/1.1 Appendix 2.4 TITLE: ACCESSION FORM FOR DEPOSIT - IMMUNOCLONES/HYBRIDOMAS Cell name: Alias(es): Depositor name: Depositor address: Depositor = originator? Y/N Originator of cell line: Address: Immunogen: Immunisation protocol: Immunocyte donor: Fusion partner: Product Ab - specificity: Subclass: Characterisation/screening assay used: Cross reactants: Applications: References (including originator if known): Any other relevant information: Recloned: Y/N Date: Ab production tested (Date): Endogenous viruses: Mycoplasma eradicated? Y/N Culture conditions: %CO2 Temp in C: Growth medium: Split ratio (attached): or (suspension): T CELLS Specificity: IL production: OTHERS Activity: IL production: Guidelines prepared for CABRI by CERDIC, DSMZ, ECACC, INRC, November 1998
© The CABRI Consortium 1999 -
2023
|